mdmx is a negative regulator of p53 activity in vivo

Rick A. Finch, Dorit B. Donoviel, David Potter, Min Shi, Amy Fan, Deon D. Freed, Ching Yun Wang, Brian P. Zambrowicz, Ramiro Ramirez-Solis, Arthur T. Sands, Nan Zhang

Research output: Contribution to journalArticlepeer-review

178 Scopus citations

Abstract

Regulation of p53 protein activity is required for normal embryogenesis, tumor suppression, and cellular response to DNA damage. Here we report that loss of mdmx, a p53-binding protein, results in midgestational embryo lethality, a phenotype that is completely rescued by the asbsence of p53. Mice homozygous for both mdmx and p53 null mutations are viable and appear developmentally normal. Fibroblasts derived from embryos with reduced mdmx expression demonstrate a decreased growth rate and increased UV-induced apoptosis compared with wild-type cells and contain elevated levels of p53 and several p53 target proteins including the proapoptotic bax protein. These observations demonstrate that mdmx functions as a critical negative regulator of p53 in vivo.

Original languageEnglish (US)
Pages (from-to)3221-3225
Number of pages5
JournalCancer Research
Volume62
Issue number11
StatePublished - Jun 1 2002
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'mdmx is a negative regulator of p53 activity in vivo'. Together they form a unique fingerprint.

Cite this